Mesothelioma Cancer Resources Blog
- Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin
Source: CancerImmunity.org People often speak mistakenly of cancer as if it were a single disease that just happens to target different areas of the body. In fact, cancer is not a single disease, but a family of diseases whose propagation is driven by a breakdown of the same cellular processes that are normally responsible for …
Label: Mesothelioma
Posted on Friday, Feb 29, 2008 - EGFR and PDGFR Differentially Promote Growth In Malignant Epitheloid Mesothelioma Of Short- And Long-term Survivors
Source: Pubmed.gov One of the most difficult aspects of a mesothelioma diagnosis for the patient and his or her family is coming to terms with the disease’s median survival figure, which states that the average life expectancy after diagnosis is only between 8 and 14 months long. Less than 10% of patients will survive for …
Label: Mesothelioma
Posted on Thursday, Feb 28, 2008 - NCGR Software Enables Identification of Mutated Genes Unique to Mesothelioma Tumors
Source: Fox Business.com The National Center for Genome Resources has announced the launch of Alpheus, the first web-based software system designed for the analysis of massive DNA sequencing projects. The system will enable researchers to analyze extremely large DNA data sets to find individual, patient-specific gene mutations. Doctors from the International Mesothelioma Program at Brigham …
Label: Mesothelioma
Posted on Tuesday, Feb 26, 2008 - Pre-Clinical Data Show Intracellular Pathways Affected by ONCONASE(R)
Source: Alfacell Corporation Alfacell Corporation has recently announced the identification of the genes and signaling pathways impacted by ONCONASE®, it’s anti-cancer drug that triggers apoptosis in malignant cells while leaving healthy cells alone. ONCONASE has shown great promise for the treatment of mesothelioma, as well as a number of other cancers. Alfacell presented this latest …
Label: Mesothelioma
Posted on Monday, Feb 25, 2008 - Las Vegas Doctor’s Cancer Drug Accepted for Human Testing
Source: Las Vegas Sun The Las Vegas Sun is running an article on the pioneering cancer research of Dr. Nam Hoang Dang, chief of hematological malignancies at the Nevada Cancer Institute. Dr. Dang has developed a compound that he believes can cure certain forms of cancer, including kidney cancer, mesothelioma and T-cell lymphoma. The FDA …
Label: Cancer Mesothelioma
Posted on Friday, Feb 22, 2008 - Symptoms and Patient-Reported Well-Being: Do They Predict Survival in Malignant Pleural Mesothelioma?
Source: Journal of Clinical Oncology, Vol 25, No 36 (December 20), 2007: pp. 5770-5776 Research into the discovery of independently-useful prognostic factors for patients with mesothelioma makes up a growing number of trials and studies. Because this disease has proven so difficult to treat, the discovery of additional factors or improvements upon current factors may …
Label: Featured Story
Posted on Thursday, Feb 21, 2008 - Malignant Pleural Mesothelioma: Surgical Management in 285 Patients
Source: The Annals of Thoracic Surgery The search for a cure for mesothelioma is a regular battle in hospitals and research facilities all over the world. The traditional modalities of cancer treatment – surgery, chemotherapy and radiation - have not yet succeeded in stopping this terrible illness, but pioneering physicians are exploring new techniques, as well …
Label: Mesothelioma
Posted on Wednesday, Feb 20, 2008 - Phase II Study of Pemetrexed in Combination with Carboplatin in Patients with Malignant Pleural Mesothelioma
Source: Annals of Oncology Surgery and chemotherapy represent the two most commonly delivered treatments for patients with any form of mesothelioma. While no single cure exists for this difficult disease, continuous research into improving both modalities has led to real, if still small, improvements in quality of life and overall survival time. The development of …
Label: Mesothelioma
Posted on Tuesday, Feb 19, 2008 - Cancer ‘Coaches’ Sway Treatment Choices
Source: Yahoo! News After the initial shock of a cancer diagnosis, one of the most difficult things for patients to do is to learn how to sift through the vast amount of data that is available about cancer treatment. Advice and support from friends and survivors can be a great benefit to patients, but the …
Label: Cancer Mesothelioma
Posted on Monday, Feb 18, 2008 - Low-dose Computed Tomography Screening for Lung Cancer and Pleural Mesothelioma in an Asbestos-Exposed Population
Source: The Oncologist Advances in imaging technologies have had a lasting impact on medical science. Better imaging techniques let doctors diagnose disease in a much more efficient manner and higher resolution scans can often be the difference between life and death. These advances are important to cancer research, especially to research in lung cancer and …
Label: Lung Cancer Mesothelioma
Posted on Friday, Feb 15, 2008



